Le Lézard
Classified in: Business
Subject: ECO

BNY Mellon Announces $830 Million Increase to Common Stock Share Repurchase Program


NEW YORK, Dec. 10, 2018 /PRNewswire/ -- BNY Mellon today announced that it has received approval from the Federal Reserve and its Board of Directors to immediately increase its repurchase program of common stock by up to an additional $830 million through the second quarter of 2019.  These repurchases are in addition to the company's repurchase of $2.4 billion of common stock previously announced on June 28, 2018.

"We are pleased that BNY Mellon is in a position to return additional capital to our shareholders through the repurchase of an additional $830 million of common stock," said Charles W. Scharf, Chairman and Chief Executive Officer.  "For more than a year, we have been working on refinements to our internal CCAR models which have been a constraint for BNY Mellon returning additional capital.  We are confident that we will continue to maintain strong capital ratios and be able to invest in our business going forward with this higher level of capital return to shareholders."

BNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment management and investment services in 35 countries. As of September 30, 2018, BNY Mellon had $34.5 trillion in assets under custody and/or administration, and $1.8 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Additional information is available on www.bnymellon.com. Follow us on Twitter @BNYMellon or visit our newsroom at www.bnymellon.com/newsroom for the latest company news.

The information presented in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be expressed in a variety of ways, including the use of future or present tense language and relate to, among other things, BNY Mellon's capital plan, including expectations on the repurchase of shares of common stock, maintaining strong capital ratios and investing in the business going forward. These statements are based upon current beliefs and expectations and are subject to significant risks and uncertainties (some of which are beyond BNY Mellon's control). Actual outcomes may differ materially from those expressed or implied as a result of risks and uncertainties, including, but not limited to, the risk factors and other uncertainties set forth in BNY Mellon's 2017 Annual Report on Form 10-K, the Quarterly Report on Form 10-Q for the period ended September 30, 2018 and BNY Mellon's other filings with the Securities and Exchange Commission. All statements in this news release speak only as of today, and BNY Mellon undertakes no obligation to update any statement to reflect events or circumstances after today or to reflect the occurrence of unanticipated events.

Contacts:

Media:
Jennifer Hendricks Sullivan
+1 212 635 1374
[email protected]

Analysts
Scott Freidenrich
+1 212 815 4008
[email protected]

SOURCE BNY Mellon


These press releases may also interest you

at 06:05
Hilton Worldwide Holdings Inc. ("Hilton," "the Company," "we," "us" or "our") today reported its first quarter 2024 results. Highlights include: Diluted EPS was $1.04 for the first quarter, and diluted EPS, adjusted for special items, was $1.53...

at 06:05
Summit Bank Group Q1 2024 Net Income - $2.4 million or $0.31 per fully diluted share. Q1 2024 Net Income increased from $0.30 per share for Q1 2023 and $0.22 per share for Q4 2023. Cash and Securities totaled $149.9 million ? 13.0 percent...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...

at 06:05
Bunge Global SA today reported first quarter 2024 results. Q1 GAAP diluted EPS of $1.68 vs. $4.15 in the prior year; $3.04 vs. $3.26 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences In Agribusiness...

at 06:05
Owens Corning , a global building and construction materials leader, today reported first-quarter 2024 results. Reported Net Sales of $2.3 Billion, in-line with Prior Year Generated Net Earnings Margins of 13%, Adjusted EBIT Margins of 19%, and...



News published on and distributed by: